Ruane, Cunniff LP, managing Sequoia Strategy, saw a 9% return in Q4 2025, outperforming the S&P 500 Index. The Strategy delivered a 21.9% return in 2025. Elevance Health, Inc. (NYSE:ELV) detracted from the Strategy’s performance in Q4. The stock closed at $327.50 on February 9, with a one-month return of -11.65%. 82 hedge fund portfolios held Elevance Health, Inc. (NYSE:ELV) at the end of Q3 2025. The company reported an operating revenue of $49.3 billion in Q4 2025, a 10% increase from the previous year. While Elevance Health, Inc. (NYSE:ELV) shows potential, other AI stocks may offer greater upside.

Read more at Yahoo Finance: Is Elevance Health (ELV) Trading at an Attractive Valuation?